Literature DB >> 16678183

Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.

Isabella Kardys1, Hok-Hay S Oei, Albert Hofman, Matthijs Oudkerk, Jacqueline C M Witteman.   

Abstract

OBJECTIVES: Although several studies have recently suggested that lipoprotein-associated phospholipase A2 (Lp-PLA2) is an independent predictor of coronary events, only one study has examined the association between Lp-PLA2 and coronary calcification, using young adults. We investigated the association between Lp-PLA2 activity and coronary calcification assessed by electron-beam computed tomography (EBT) in a population of older participants. METHODS AND
RESULTS: The Rotterdam Coronary Calcification Study is a population-based study in men and women aged >/=55 years. Coronary calcification assessed by EBT was quantified in a calcium score according to Agatston's method. Lp-PLA2 activity measured in samples collected 7 years before scanning (n=520) was associated with coronary calcification in men after adjustment for age. The odds ratio per standard deviation of Lp-PLA2 activity of having a total calcium score >1000 was 1.6 (95% confidence interval: 1.1-2.4), as compared to a total calcium score </=100. After adjustment for non-HDL and HDL-cholesterol, this association disappeared. In women, the association was less consistent. For Lp-PLA2 measured concurrently to scanning (n=703), no association was found with coronary calcification.
CONCLUSIONS: Lp-PLA2 activity is moderately associated with coronary calcification after adjustment for age. The effect of Lp-PLA2 on coronary calcification may be exerted through its effect on LDL-cholesterol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678183     DOI: 10.1016/j.atherosclerosis.2006.04.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.

Authors:  A Ross Eckard; C T Longenecker; Y Jiang; S M Debanne; D Labbato; N Storer; G A McComsey
Journal:  HIV Med       Date:  2014-03-20       Impact factor: 3.180

2.  Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.

Authors:  Parveen K Garg; Robyn L McClelland; Nancy S Jenny; Michael H Criqui; Philip Greenland; Robert S Rosenson; David S Siscovick; Neal Jorgensen; Mary Cushman
Journal:  Atherosclerosis       Date:  2015-05-16       Impact factor: 5.162

3.  Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.

Authors:  Gregory L Kinney; Janet K Snell-Bergeon; David M Maahs; Robert H Eckel; James Ehrlich; Marian Rewers; John E Hokanson
Journal:  Diabetes Technol Ther       Date:  2011-02-03       Impact factor: 6.118

4.  Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women.

Authors:  Ida J Hatoum; Nancy R Cook; Jeanenne J Nelson; Kathryn M Rexrode; Eric B Rimm
Journal:  Am Heart J       Date:  2011-01-31       Impact factor: 4.749

5.  Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis.

Authors:  Jing Liu; Yuling Hong; Yue Qi; Fan Zhao; Dong Zhao
Journal:  N Am J Med Sci (Boston)       Date:  2011-10

6.  Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.

Authors:  Eugenia Raichlin; Joseph P McConnell; Jang-Ho Bae; Walter K Kremers; Amir Lerman; Robert P Frantz
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

Review 7.  Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?

Authors:  Natalie Khuseyinova; Wolfgang Koenig
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  Optimization of a Protocol for Protein Extraction from Calcified Aortic Valves for Proteomics Applications: Development of a Standard Operating Procedure.

Authors:  Fábio Trindade; Ana F Ferreira; Francisca Saraiva; Diana Martins; Vera M Mendes; Carla Sousa; Cristina Gavina; Adelino Leite-Moreira; Bruno Manadas; Inês Falcão-Pires; Rui Vitorino
Journal:  Proteomes       Date:  2022-09-01

9.  Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men.

Authors:  Aiman El-Saed; Akira Sekikawa; Riad Wahid Zaky; Takashi Kadowaki; Tomoko Takamiya; Tomonori Okamura; Daniel Edmundowicz; Yoshikuni Kita; Lewis H Kuller; Hirotsugu Ueshima
Journal:  J Epidemiol       Date:  2007-11       Impact factor: 3.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.